ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Curcumin sulfate

HCID 66645351
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
339286-19-0
標準SMILES
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(OC)c2)ccc1O
InChIKey
NEJVQQBBTRFOHB-FCXRPNKRSA-N
分子式
C21H20O9S
平均分子量
448.4 g/mol
単同位体質量
448.08280338

概要

Curcumin sulfate is a diarylheptanoid.

名称と識別子

優先名称
Curcumin sulfate
IUPAC
[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl]-2-methoxyphenyl] hydrogen sulfate
英語名
Curcumin Sulfate Sodium Salt
分子式
C21H20O9S
分子量
448.44

名称と別名

Curcumin sulfateCurcumin sulphate339286-19-0Curcumin monosulfateUNII-160DHE331M160DHE331M1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(3-methoxy-4-(sulfooxy)phenyl)-, (1E,6E)-4-((1E,4Z,6E)-5-Hydroxy-7-(4-hydroxy-3-methoxyphenyl)-3-oxohepta-1,4,6-trien-1-yl)-2-methoxyphenyl hydrogen sulfateDTXSID10893526{4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl]-2-methoxyphenyl}oxidanesulfonic acid(4-((1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl)-2-methoxyphenyl)oxidanesulfonic acidRefChem:128879
名称をさらに表示
Curcumin Sulfate-d6Curcumin sulfate triethylamineCurcumin-O-Sulfate DISCONTINUED, offer C838520Curcumin monosulfate/Curcumin sulfate/Curcumin Sulfate Tetrabutylammonium Salt1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-[3-methoxy-4-(sulfooxy)phenyl]-, (1E,6E)-Curcumin Sulfate Sodium saltQ: What is Curcumin Sulfate Sodium salt Q: What is the CAS Number of Curcumin Sulfate Sodium salt Q: What is the storage condition of Curcumin Sulfate Sodium salt Q: What are the applications of Curcumin Sulfate Sodium salt
DTXCID001323548NOCAS_8935264-((1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl)-2-methoxyphenyl hydrogen sulfateCurcumin Sulfate Sodium Salt[4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl]-2-methoxyphenyl] hydrogen sulfate4-[(1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dien-1-yl]-2-methoxyphenyl hydrogen sulfateCurcumin Impurity 12SCHEMBL290796

データベース識別子

CAS
339286-19-0
PubChem CID
66645351
DTXSID
DTXSID10893526
ChEBI
CHEBI:189746
UNII
160DHE331M
Nikkaji
J3.281.992C

物性

構造計算による物性補完中

XLogP
2.6
極性表面積
145 Ų
水素結合供与体数
2
水素結合受容体数
9
回転可能結合数
10
重原子数
31
形式電荷
0
複雑度
768

物理化学的性質

溶解性
DMSO (Slightly), Methanol (Sparingly)
外見
Solid
色
Yellow to Dark Yellow
安定性
Hygroscopic

化学と産業

薬理情報

Protein BindingNo pharmacokinetic data available.
Pharmacodynamics · 1 件

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.

Mechanism of Action · 1 件

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2.

Biological Half-LifeNo pharmacokinetic data available.
Metabolism/Metabolites · 1 件

Initially, curcumin undergoes rapid intestinal metabolism to form curcumin glucuronide and curcumin sulfate via O-conjugation. Other metabolites formed include tetrahydrocurcumin, hexahydrocurcumin, and hexahydrocurcuminol via reduction. Curcumin may also undergo intensive second metabolism in the liver where the major metabolites were glucuronides of tetrahydrocurcumin and hexahydrocurcumin, with dihydroferulic acid and traces of ferulic acid as further metabolites. Hepatic metabolites are expected to be excreted in the bile. Certain curcumin metabolites, such as tetrahydrocurcumin, retain anti-inflammatory and antioxidant properties.

Absorption, Distribution and Excretion · 4 件

Curcumin displays poor absorption into the gastrointestinal tract. In a rat study, oral administration of a single dose of 2 g of curcumin resulted in a plasma concentration of less than 5 μg/mL, indicating poor absorption from the gut.

Following oral administration of curcumin to rats at a dose of 1 g/kg bw, about 75% of dose was excreted in the faeces and only traces of the compound was detected in the urine. When a single 400 mg dose of curcumin was administered orally to rats, about 60% was absorbed and 40% was excreted unchanged in the faeces over an period of 5 days. Intraperitoneal administration resulted in fecal excretion of 73% and biliary excretion of 11%.

Following oral administration of radio-labelled curcumin to rats, radioactivity was detected in the liver and kidneys.

No pharmacokinetic data available.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性化学と産業関連反応化合物ノート